About us

About us

Janssen With Me

Welcome to Janssen With Me, a compassionate sub-brand of Janssen dedicated to providing invaluable support and information to patients and their family and friends navigating through challenging health journeys. As a subsidiary of Janssen, a global leader in healthcare innovation and pharmacy (www.janssen.com), Janssen With Me is committed to making a difference in the lives of individuals facing health challenges.

Here for you

At Janssen With Me, we understand that facing a medical condition can be one of the toughest periods in one's life. That's why we've created a platform that goes beyond providing information – we aim to be a supportive companion throughout your healthcare journey. Our mission is to empower patients and their partners by offering relevant medical insights, resources, and a sense of community. We believe that informed individuals are better equipped to make decisions about their health, and we're here to facilitate that empowerment.

On our user-friendly website, you'll find a wealth of resources tailored to your specific needs. Whether you're seeking medical information, practical advice, or emotional support, Janssen With Me is designed to be a comprehensive resource hub. Each country's version of the website is customized to cater to local healthcare nuances, ensuring that you receive information relevant to your specific region. Our commitment to inclusivity extends to partnerships with healthcare professionals and organizations to provide a well-rounded support network.

More than a website

Janssen With Me is not just a website; it's a community that understands the importance of connection during challenging times. Through our platform, we encourage individuals to share their stories, insights, and tips, fostering a sense of unity and understanding. Together, we can navigate the complexities of health challenges, armed with knowledge, support, and the strength that comes from a community that cares. Join us on this journey – let's face the future with knowledge, resilience, and compassion.

Select a country to see country specific content

Want to learn more about Janssen?

Janssen website

The Janssen Pharmaceutical Companies of Johnson & Johnson are uniquely positioned and privileged to make a positive difference to the lives of patients and their loved ones, at all stages of life.


Myasthenia Gravis Foundation of America (MGFA). A Manual for the Healthcare Provider. Available at: https://myasthenia.org/Portals/0/Provider%20Manual_ibook%20version.pdf Last accessed: June 2024.
National Institute of Neurological Disorders and Stroke (NINDS). Myasthenia Gravis. Available at: https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis Last accessed: June 2024.
Dewilde S, et al. People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies. Adv Ther. Vol 40, 4377–4394 (2023). Available at: https://doi.org/10.1007/s12325-023-02604-z Last accessed: June 2024.
Mahic, et al. Healthcare resource use in myasthenia gravis: a US health claims analysis. Ther Adv Neurol Disorders (2023). Available at: https://doi.org/10.1177/17562864221150327 Last accessed: June 2024.
Daum P et al. Perioperative management of myasthenia gravis. BJA Education (2021) 21(11): 414e419
John Hopkins Medicine. Myasthenia Gravis. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/myasthenia-gravis Last accessed: June 2024.
Mishra A, et al. Myasthenia Gravis: A Systematic Review. Cureus (2023) 15(12): e50017. DOI 10.7759/cureus.50017.
Luo H, Xie S, Ma C, Zhang W, Tschöpe C, Fa X, Cheng J, Cao J. Correlation Between Thymus Radiology and Myasthenia Gravis in Clinical Practice. Front Neurol. 2019 Jan 15;9:1173. doi: 10.3389/fneur.2018.01173. PMID: 30697185; PMCID: PMC6340958.
Chen J, Tian D-C, Zhang C, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. The Lancet Regional Health - Western Pacific. 2020;5(100063). https://doi.org/10.1016/j.lanwpc.2020.100063.
Lazaridis K, et al. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Front Immunol. 2020 Feb 14;11:212. doi: 10.3389/fimmu.2020; 00212. Last accessed: June 2024.
Myasthenia Gravis Foundation of America (MGFA). Seronegative MG Resource Center. Available at: https://myasthenia.org/Newly-Diagnosed/Seronegative-MG-Resource-Center Last accessed: June 2024.
Jackson et al. Understanding the symptom burden and impact of myasthenia gravis from the patient’s perspective: A qualitative study. Neurology and Therapy. 2022;12:1; 107–128. Available at: https://doi.org/10.1007/s40120-022-00408-x.
Myasthenia Gravis Foundation of America (MGFA). Myasthenia Gravis Clinical Overview. Available at: https://myasthenia.org/Professionals/Clinical-Overview-of-MG#DIAGNOSTIC. Last accessed: June 2024
NHS. Myasthenia Gravis. Available at: https://www.nhs.uk/conditions/myasthenia-gravis/ Last accessed: June 2024.
NHS. Diagnosis Myasthenia Gravis. Available at: https://www.nhs.uk/conditions/myasthenia-gravis/diagnosis/ Last accessed: June 2024.